INIS
patients
100%
tuberculosis
65%
covid-19
56%
indonesia
54%
hospitals
32%
diseases
24%
drugs
24%
risks
18%
mortality
16%
adults
16%
data
15%
reviews
13%
comparative evaluations
12%
symptoms
12%
coronaviruses
11%
therapy
10%
values
10%
levels
9%
WHO
9%
death
9%
vaccines
8%
management
8%
safety
8%
aspergillus
8%
doses
7%
income
7%
pneumonia
7%
evaluation
7%
antibodies
7%
units
6%
injuries
6%
isoniazid
6%
sensitivity
6%
control
6%
lungs
6%
antibiotics
6%
viruses
6%
conversion
6%
ventilation
6%
cancer
5%
pcr
5%
inflammation
5%
humans
5%
chest
5%
diabetes mellitus
5%
cost
5%
curves
5%
detection
5%
Keyphrases
Indonesia
56%
COVID-19
42%
Tuberculosis
26%
Tuberculosis Patients
21%
Jakarta
20%
Multidrug-resistant Tuberculosis (MDR-TB)
19%
Pulmonary Tuberculosis
16%
COVID-19 Patients
11%
Comorbidity
10%
Chronic Pulmonary Aspergillosis
8%
Patients with COVID-19
8%
Hospitalized Patients
8%
Severe COVID-19
7%
Tuberculosis Treatment
7%
Vaccine Effectiveness
7%
TB Patients
6%
Clinical Outcomes
6%
Intensive Care Unit
6%
Quantitative PCR
6%
Low-middle Income Countries
5%
Latent Tuberculosis Infection
5%
Pada
5%
International Cohort
5%
Medicine and Dentistry
COVID-19
44%
Infection
12%
Lung Tuberculosis
9%
Diseases
9%
Comorbidity
8%
Drug Resistant Tuberculosis
8%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Rifampicin
7%
Multidrug Resistant Tuberculosis
7%
Intensive Care Unit
6%
Observational Study
6%
Tuberculosis
6%
Diagnosis
6%
Artificial Respiration
6%
Sputum Culture
5%
Chronic Pulmonary Aspergillosis
5%
Lung Cancer
5%
Sputum
5%